ERBB2 and neoplasm: We did not increase the injected dose further, as the results of the previous study with anti-HER2 affibody molecules have shown that increase of affibody dose to 5 μg per mouse causes appreciable reduction of tumour uptake in LS174T xenografts expressing 4 × 104 receptors per cell42.